Combine high risk factors with circulating tumor DNA (ctDNA) to assist adjuvant chemotherapy ( ACT) decision in Stage II colorectal cancer (CRC)

被引：0
|
作者：
Yuan, Xie Gui [1 ]
Miao, Liu [2 ]
Li, Huang Meng [2 ]
机构：
[1] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5115
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.
    Kasi, Pashtoon Murtaza
    Aushev, Vasily N.
    Ensor, Joe
    Langer, Nathan
    Wang, Christopher Gene
    Cannon, Timothy Lewis
    Berim, Lyudmyla Derby
    Feinstein, Trevor
    Grothey, Axel
    McCollom, Joseph William
    Kalmadi, Sujith R.
    Zakari, Ahmed
    Dayyani, Farshid
    Gravenor, Donald
    Meyer, Janelle Marie
    Sharif, Saima
    Jurdi, Adham A.
    Liu, Minetta C.
    Aleshin, Alexey
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 9 - 9
  • [2] Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
    Akagunduz, Baran
    Guven, Deniz Can
    Ozer, Muhammet
    Okten, Ilker Nihat
    Atag, Elif
    Unek, Ilkay Tugba
    Tatli, Ali Murat
    Karaoglu, Aziz
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (02)
  • [3] Novel clinical decision support (CDS) system optimizing adjuvant chemotherapy (ACT) for colorectal cancer (CRC) by integrating deep learning and circulating tumor DNA (ctDNA) molecular residual disease (MRD): GALAXY histotyping
    Nakamura, Y.
    Kildal, W.
    Misumi, T.
    Pradhan, M.
    Watanabe, J.
    Skrede, O-J
    Kotani, D.
    Raedt, S. D.
    Bando, H.
    Kalsnes, J.
    Taniguchi, H.
    Liestol, K.
    Takemasa, I.
    Hveem, T. S.
    Kato, T.
    Novelli, M.
    Oki, E.
    Kerr, D. J.
    Yoshino, T.
    Kleppe, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S457 - S458
  • [4] Detection of Mutant Circulating Tumor DNA (ctDNA) in Plasma of Patients With Colorectal Cancer (CRC)
    Dworniczak, Juliane
    Rossenbach, Christiana
    Reisch, Simone
    Hart, Christian
    Fuzesi, Laszlo
    Dockhorn-Dworniczak, Barbara
    Dworniczak, Bernd
    LABORATORY INVESTIGATION, 2015, 95 : 513A - 513A
  • [5] Detection of Mutant Circulating Tumor DNA (ctDNA) in Plasma of Patients With Colorectal Cancer (CRC)
    Dworniczak, Juliane
    Rossenbach, Christiana
    Reisch, Simone
    Hart, Christian
    Fuzesi, Laszlo
    Dockhorn-Dworniczak, Barbara
    Dworniczak, Bernd
    MODERN PATHOLOGY, 2015, 28 : 513A - 513A
  • [6] Multimodal circulating tumor DNA (ctDNA) colorectal neoplasia detection assay for asymptomatic and early-stage colorectal cancer (CRC).
    Lee, Jeeyun
    Kim, Hee C.
    Kim, Seung Tae
    He, Yupeng
    Sample, Paul
    Nakamura, Yoshiaki
    Raymond, Victoria M.
    Jaimovich, Ariel
    Talasaz, AmirAli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Use of circulating tumor DNA (ctDNA) to affect the adjuvant or post-adjuvant treatment of patients with stage III and high-risk stage II resected colon cancer: The ERASE-CRC project by GONO
    Conca, Veronica
    Vetere, Guglielmo
    Moretto, Roberto
    Lonardi, Sara
    Antoniotti, Carlotta
    Germani, Marco Maria
    Pietrantonio, Filippo
    Bittoni, Alessandro
    Carullo, Martina
    Salvatore, Lisa
    Boccaccino, Alessandra
    Ronzoni, Monica
    Ricagno, Gianmarco
    Toma, Ilaria
    Cupini, Samanta
    Latiano, Tiziana Pia
    Arcangeli, Giuseppina
    Masi, Gianluca
    Fassan, Matteo
    Cremolini, Chiara
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA).
    Diehn, Maximilian
    Alizadeh, Ash A.
    Adams, Hans-Peter
    Lee, John J.
    Klassen, Susanne
    Palma, John F.
    Hinzman, Bernd
    Lovejoy, Alexander F.
    Newman, Aaron M.
    Yao, Lijing
    Yaung, Stephanie
    Balasubramanyam, Aarthi
    Rohr, Ulrich Peter
    Rosenthal, Andre
    Kube, Rainer
    Steinmueller, Thomas
    Marusch, Frank
    Mantke, Rene
    Heise, Michael
    Pross, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Circulating tumor DNA (ctDNA) in nonmetastatic colorectal cancer (CRC): Potential role as a screening tool
    Tie, Jeanne
    Wang, Yuxuan
    Kinde, Isaac
    Steel, Malcolm
    Elsaleh, Hany
    Singh, Madhu Sudan
    Turner, Natalie Heather
    Tran, Ben
    Strausberg, Robert
    Diaz, Luis A.
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
    Tie, Jeanne
    Kinde, Isaac
    Wang, Yuxuan
    Wong, Hui-li
    Skinner, Iain
    Wong, Rachel
    Steel, Malcolm
    Diaz, Luis A.
    Papadopoulos, Nickolas
    Kosmider, Suzanne
    Yip, Desmond
    Underhill, Craig
    Haydon, Andrew Mark
    Christie, Michael
    Strausberg, Robert
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345